BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Understanding the differences between value and growth investing is essential. Learn how to choose the right approach for your goals.
24,909 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
Fluor dropped 26% and headlines lit up. But a solid long-term thesis for this EPC powerhouse requires more than a fla...
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
You don’t need a wall street star to beat the market. A thoughtfully chosen low-cost that could outperform fund manag...
An insider sold 50,000 shares of Hinge Health, prompting questions about the stock’s outlook. This guide breaks down ...
Global tensions keep defense spending strong. This guide identifies why the best defense industry stock may offer sta...
A major liquidity event reshapes the landscape for SmartStop Self Storage REIT and its stakeholders. This deep dive e...
A simple, cost-conscious tilt of two Vanguard index funds could help you outpace the S&P 500 over the next year. This...
As volatility persists in 2026, savvy investors are exploring the tax advantages of placing Main Street Capital in a ...
Private equity is moving from wall street legends to the everyday investor. Here’s how cathie wood's private equity i...
Archer Aviation stock soaring headlines are turning heads in the investing world. This article breaks down what’s fue...